Plants as bioreactors for biopharmaceuticals: regulatory considerations

• 28 February 1997
• journal article
• review article
• Published by Elsevier in Trends in Biotechnology
• Vol. 15  (2) , 45-50
• https://doi.org/10.1016/s0167-7799(97)84202-3

Abstract

Keywords

• BIOTECHNOLOGY
• BIOPHARMACEUTICALS
• MONOCLONAL ANTIBODIES
• CYTOKINES
• VACCINES
• RECOMBINANT
• GAINED
• CONSIDERATIONS PLANTS
• REGULATORY CONSIDERATIONS
• CLINICAL DEVELOPMENT